IMAX (IMAX) moved back into the spotlight after reporting second quarter 2026 results, with revenue of $102.84 million and net income of $15.4 million, alongside ongoing share repurchases and new technology partnerships.

IMAX stock has pulled back slightly in the last session, with a 1 day share price return that declined 1.32%, but the 7 day share price return of 12.38% and year to date share price return of 20.43% sit alongside a 1 year total shareholder return of 60.85% and 5 year total shareholder return of 170.96%. This points to momentum that has built over time as investors react to recent earnings, buybacks and new partnerships.

If the IMAX story has you thinking about where else growth and technology intersect, this is a good moment to scan the market for 55 AI infrastructure stocks

After a sharp run and fresh partnerships, IMAX now trades about 16% below the average analyst price target and at a wider intrinsic discount of roughly 49%. Is that a margin of safety or a warning sign?

Most Popular IMAX Narrative: 7.3% Undervalued

With IMAX trading at $43.38 against a widely followed fair value narrative of $46.82, the stock sits at a modest implied discount that hinges on how earnings and margins evolve from here.

Diversification of content offerings, including local-language blockbusters, alternative content (concerts, live events), and deeper relationships with streaming and tech partners like Apple, Amazon, and Netflix, is broadening IMAX's audience base and improving margin mix. This is contributing to higher contribution per screen and more resilient earnings.

Want to see what sits behind that fair value gap for IMAX? The narrative leans on faster revenue traction, fatter margins, and a future earnings profile that looks very different to today. Curious which assumptions matter most and how they connect to that valuation path?

Result: Fair Value of $46.82 (UNDERVALUED)

However, IMAX investors still need to weigh the risk that at-home entertainment continues to pull audiences away from cinemas and that rival premium formats pressure pricing and new installations.

Another View: IMAX Valuation Through Earnings Multiples

The earlier fair value argument for IMAX leans on discounted future cash flows, yet the current P/E of 58.1x tells a different story. That multiple sits well above the US Entertainment industry at 22.4x, peers at 47.7x, and even the 22.3x fair ratio our model suggests the market could move toward. For investors, that gap raises a simple question: is the current price reflecting optimism that may already be in the stock, or a premium that could be at risk if expectations cool?

For a closer look at how this earnings based view stacks up against the detailed valuation work, take a moment to review the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Seeing both optimism and concern around IMAX in the numbers and narratives, this is a moment to move quickly and test the thesis against your own expectations by weighing the data on both sides, including the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond IMAX?

If the IMAX narrative has sharpened your thinking, do not stop here. Broaden your watchlist now and let the numbers point you toward your next opportunity.

• Target potential mispricings by scanning a curated set of 50 high quality undervalued stocks that pair robust fundamentals with prices the market may not fully credit yet.
• Strengthen income potential by reviewing 9 dividend fortresses that focus on higher yields backed by business models built for regular cash returns.
• Protect your downside by zeroing in on 84 resilient stocks with low risk scores that score well on resilience so you are not relying on one stock to carry your portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.